Video

Yi Cai, MD: Improving Sleep Care in Minority Communities

Author(s):

The results of the study presented at SLEEP 2023 were statistically significant, but not clinically meaningful.

New research presented during the SLEEP 2023 Annual Conference in Indianapolis shows that Black patients with obstructive sleep apnea had a statistically significant, yet a clinically insignificant difference in mean positive airway pressure level compared to White patients.

In the study, a team of investigators led by Yi Cai, MD, Associate Fellow, Sleep Medicine and Sleep Surgery at the University of Pennsylvania, retrospectively looked at adult patients with OSA who were prescribed auto-adjusting PAP (aPAP) therapy at a single academic center between January 2018 and January 2020.

The results of the 378 patient study show Black patients on average had less severe disease, although the difference was not statistically significant.

In addition, Black patients had a 0.62 cm H2O (95% confidence interval [CI], 0.21-1.03) higher mean PAP level than White patients (P = 0.003). There was also a larger racial difference found in the mean PAP level among men (0.76 cm H2O; 95% CI, 0.16-1.35; P = 0.013) compared to a non-significant difference among women (0.34 cm H2O 95% CI, -0.23 to 0.91; P = 0.242).

In an interview with HCPLive®, Cai talked about the results and why it is important to study racial differences when assessing and deciding on the right course of action for patients with OSA and other sleep disorders.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.